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Yessotoxins (YTXs) are algal toxins that can be accumulated in edible molluscs. YTX treatment of MCF-7 breast cancer cells causes
the accumulation of a 100kDa fragment of E-cadherin, which we have named ECRA100. A relative decrease in the concentrations of
intact E-cadherin did not accompany the accumulation of ECRA100 in cytosoluble extracts of MCF-7 cells on the first day of YTX
treatment, but a collapse of the E-cadherin system was detected after 2–5 days of treatment with the toxin. An analysis of the
general structure of ECRA100 revealed that it consists of an E-cadherin fragment lacking the intracellular domain of the protein.
ECRA100 was not released into culture media of YTX-treated cells. Accumulation of ECRA100 was observed in other epithelial cells,
such as human intestine Caco-2 and MDCK cells after treatment with YTX. In turn, YTX could not induce accumulation of fragments
of other members of the cadherin family, such as N-cadherin in the PC12 cell line and K-cadherin in sensitive cells (MCF-7, Caco-2,
MDCK). The accumulation of a 100kDa fragment of E-cadherin devoid of its intracellular domain induced by YTX was accompanied
by reduced levels of b- and g-catenins bound to E-cadherin, without a concomitant decrease in the total cytosoluble pools of b- and
g-catenins. Taken together, the results we obtained show that YTX causes the selective disruption of the E-cadherin–catenin system
in epithelial cells, and raise some concern about the potential that an algal toxin found in seafood might disrupt the tumour
suppressive functions of E-cadherin.
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E-cadherin belongs to a large family of proteins responsible for the
Ca
2þ-dependent cell–cell adhesion, which is involved in cell
recognition, pattern formation and proper development of the
embryo (Takeichi, 1990; Yap et al, 1997; Tepass et al, 2000). In
adult vertebrates, E-cadherin is typically expressed in the cells of
epithelia, where it plays a role of tumour suppressor (Vleminckx
et al, 1991; Christofori and Semb, 1999), through the stabilisation
of cell–cell adhesion by homophilic interactions between mole-
cules projecting extracellularly from two contiguous cells (Vestwe-
ber and Kemler, 1985; Vleminckx et al, 1991; Christofori and
Semb, 1999).
The proper functioning of E-cadherin depends on several
portions of the protein molecule. The mature form of E-cadherin,
in fact, consists of a transmembrane protein with an extended
glycosilated amino-terminal exposed to the exterior of the cell,
which contains the Ca
2þ-binding sites and mediates the homo-
philic adhesion. The carboxy-terminal, intracellular domain, in
turn, is involved in supramolecular structures containing catenins
and other cytosolic proteins, mediating proper attachment of E-
cadherin to the actin cytoskeleton (Ozawa et al, 1989; Mareel et al,
1997; Christofori and Semb, 1999; Beavon, 2000; Nollet et al, 2000).
Thus, alterations in the expression as well as in the structure of E-
cadherin and catenins have been linked to tumour progression,
tumour cell invasion and metastasis formation in breast, intestine
and prostate cancers (Birchmeier and Behrens, 1994; Mareel et al,
1997; Christofori and Semb, 1999; Beavon, 2000).
Yessotoxins (YTXs) represent a group of polyether sulphated
compounds (Yasumoto and Murata, 1993), which are produced by
algae, such as Protoceratium reticulatum (Satake et al, 1997;
Ciminiello et al, 2003). These natural compounds are included
among algal toxins because i.p. injection of yessotoxin into mice leads
to death at doses as low as 80mgkg
 1 (Murata et al, 1987; Ciminiello
et al, 1997; Ogino et al, 1997). As YTXs can be accumulated in edible
molluscs, such as scallops and mussels (Murata et al, 1987; Ciminiello
et al, 1997), by filter feeding, the current European legislation sets the
limits of YTX contamination in material destined to human
consumption (European Communities, 2002).
Oral ingestion of YTX at doses as high as 2mgkg
 1 has not led
to mouse death and detection of severe organ damage (Aune et al,
2002; Tubaro et al, 2003), but ultrastructural alterations of
cardiomyocytes have been observed by electron microscopy of
tissue samples from mice that ingested high YTX doses (Tubaro
et al, 2003). Long-term effects of YTX, in turn, have not been
reported, yet.
In the course of our investigations onto the molecular bases of
YTX action in cultured cells, we found that treatment of MCF-7
breast cancer cells with subnanomolar concentrations of YTX led
to the accumulation of a 100kDa fragment of E-caderin, which we
have named ECRA100 (Pierotti et al, 2003).
Due to the possibility that disruption of E-cadherin functioning
might favour tumour cell invasion and metastasis formation, and
in the light of the very low effective concentrations of YTX in our
experimental system, we have approached an analysis of the
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salterations induced by YTX in different cadherin molecules in
cultured cells.
In this paper, we show that YTX causes the selective removal of
the cytoplasmic domain of E-cadherin in epithelial cells, where it
disrupts the E-cadherin–catenin system.
MATERIALS AND METHODS
Materials
Yessotoxin was obtained from the Institute of Environmental
Science and Research Limited (Lower Hutt, New Zealand) and
from Patrizia Ciminiello (Universita ` di Napoli, Napoli, Italy).
Anti-E-cadherin antibodies were purchased from Santa Cruz
Biotechnology (H-108), Transduction Laboratories (C20820) and
Alexis Corporation (HECD-1). The anti-N-cadherin antibody was
purchased from Assay Designs. The anti-K-cadherin antibody was
purchased from Santa Cruz Biotechnology. The anti-b-catenin and
anti-g-catenin antibodies were obtained from Transduction
Laboratories.
Peroxidase-linked anti-rabbit and anti-mouse Ig antibodies, the
protein G-Sepharose
r and the enhanced chemioluminescence
(ECL) detection reagents were from Amersham Biosciences, and
the peroxidase-linked anti-goat Ig antibody was purchased from
Santa Cruz Biotechnology.
The anti-actin antibody and prestained molecular mass markers
were obtained from Sigma. The nitrocellulose membrane Protran
BA 83 was obtained from Schleicher and Schuell. All other reagents
were of analytical grade.
Cell culture conditions and treatments
Cell cultures were grown in 5% carbon dioxide in air at 371C, in
90-mm diameter Petri dishes. MCF-7 cells were obtained from the
European Collection of Animal Cell Cultures (ECACC No.
86012803; CB No. CB 2705), and their culture medium was
composed of Dulbecco’s modified Eagle medium, containing 1%
nonessential amino acids and 10% foetal calf serum.
Caco-2 cells were obtained from the American Type Culture
Collection (ATCC No. HTB-37), their culture medium was
composed of minimum essential medium with Earle’s BSS,
containing 2mM glutamine, 2.2gl
 1 sodium bicarbonate, 1mM
sodium pyruvate, 1% nonessential amino acids and 20% foetal
calf serum.
PC-12 cells were obtained from the American Type Culture
Collection (ATCC No. CRL-1721), and their culture medium was
composed of RPMI 1640, containing 2mM glutamine, 4.5gl
 1
glucose, 2gl
 1 sodium bicarbonate, 10mM HEPES, 1mM sodium
pyruvate, 10% heat-inactivated horse serum and 5% foetal calf
serum. These cells adhered poorly to plastic and tended to grow in
small clusters. In our experimental conditions, attachment was
improved by cell seeding in collagen-coated dishes (9mg
collagen cm
 2 solution). In some experiments, cell differentiation
was stimulated by medium supplementation with 50nM nerve
growth factor (NGF) for 72h at 371C, according to Greene and
Tischler (1976).
Madin Darby canine kidney (MDCK) cells were obtained from
the American Type Culture Collection (ATCC No. CCL-34), and
their culture medium was composed of minimum essential
medium with Earle’s salts, containing 2mM glutamine, 1mM
sodium pyruvate, 1% nonessential amino acids and 10% foetal
calf serum.
Stock solutions (1mM) of YTX were prepared by dissolving the
compound in absolute ethanol, and were stored in glass vials
protected from light at  201C. If not stated otherwise, cell
treatments were carried out using dishes near confluency, by
addition of 1nM YTX and incubations for 24h at 371C. Parallel
dishes received the addition of absolute ethanol (control samples).
Preparation of cell extracts
The experimental procedure was carried out at 21C. If not stated
otherwise, cells from culture dishes were washed once with PBS,
harvested with PBS containing 1mM EDTA and transferred to
centrifuge tubes. MDCK cells were washed twice with PBS, and
were then harvested by scraping. The cell suspensions were
centrifuged for 8min at 800g, dispersed in PBS and centrifuged for
8min at 800g. The cell pellets were lysed with 0.5ml PBS
containing 1% (vv
 1) Triton X-100 (TX buffer) and 0.1mgml
 1
phenylmethylsulphonyl fluoride and with two 10s bursts of
vortexing. Cytosoluble extracts were then obtained by centrifuga-
tion for 30min at 16000g. The supernatants of this centrifugation
were then brought to 2% SDS and 5% b-mercaptoethanol, to be
used for fractionation by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS–PAGE).
When the distribution of components between the Triton X-100-
soluble and insoluble fractions was carried out, the precipitates
obtained after the lysates had been centrifuged for 30min at
16000g were extracted by dispersion with 20mM Tris-HCl, pH 7.5
at 21C, 2% SDS, 1mM CaCl2, and were then subjected to
centrifugation for 1h at 105000g. The supernatants of this
centrifugation were brought to 5% b-mercaptoethanol and were
used for SDS–PAGE.
The protein content of cellular extracts was measured with
bicinchoninic acid (Smith et al, 1985).
When cell proliferation was evaluated, both adherent and
floating cells were harvested and washed three times by resuspen-
sion in 4ml of PBS, and low-speed centrifugation. The material
remaining attached to the substratum was washed with PBS, was
harvested with 20mM Tris-HCl, pH 7.5 at 21C, 1.5mM EDTA (TE
buffer) and was combined with its respective sediment. The
resulting cellular suspension was then lysed by sonication with one
10s burst, and the homogenate was used for DNA measurements
by the procedure of Labarca and Paigen (1980).
Immunoprecipitation of E-cadherin–catenin complexes
The samples used in this procedure consisted of cytosoluble
extracts prepared as described, but lysing MCF-7 cells by a TX
buffer containing a mixture of protease inhibitors including 2mM
4-(2-aminoethyl)benzenesulphonyl fluoride, 1mM EDTA, 130mM
bestatin, 14mM E-64, 1mM leupeptin and 0.3mM aprotinin.
Cytosoluble extracts were pretreated with protein G-Sepharose
r
for 1h at 21C. The treated extracts were recovered by low-speed
centrifugation and were incubated with 1mg HECD-1 anti-E-
cadherin antibody/700mg of cytosoluble protein for 1h at 21C. At
the end of the incubation, 50ml of protein G-Sepharose
r was
added to each sample and incubation was continued for 1h at 21C.
The affinity matrix was then recovered by centrifugation for 4min
at 16000g, and was then washed twice by resuspension in 0.2ml of
PBS buffer, and centrifugation for 4min at 16000g through a
0.5ml cushion of 10% sucrose in PBS buffer. The material bound
to the affinity matrix was then extracted with 100ml of TE buffer
containing 4% (wv
 1) SDS, 10 % b-MSH and 40 % (vv
 1) glycerol,
and was recovered by centrifugation for 4min at 16000g. Samples
were then subjected to SDS–PAGE.
Fractionation of proteins by SDS–PAGE and
immunoblotting
Samples containing the same amount of protein were fractionated
by SDS–PAGE, according to Laemmli (1970), using a 10%
separating gel and 3% stacking gel. After completion of electro-
phoresis, proteins were electrophoretically transferred onto a
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snitrocellulose membrane (Protran BA 83), and binding sites
remaining on the membrane were blocked by incubation of blots
for 1h at room temperature with 20mM Tris-HCl, pH 7.5 at 251C,
0.15 M NaCl and 0.05% (vv
 1) Tween 20 (immunoblotting buffer),
containing 3% non-fat dry milk. When immunoblotting was used
to detect cadherins, the immunoblotting buffers used for blocking
unspecific sites on the membrane and for the incubation with
primary antibodies did not include Tween 20, but contained 1mM
CaCl2. After blocking unspecific sites, the membranes were
incubated for 1h at room temperature with immunoblotting
buffer, containing 1% non-fat dry milk and the primary antibody
at a final concentration ranging between 0.1 and 2mgml
 1,
depending on the antigen to be detected. After incubation,
membranes were washed five times with immunoblotting buffer,
and incubated for 1h at room temperature with a peroxydase-
linked secondary antibody at a 1:3000 or 1:2000 dilution in
immunoblotting buffer containing 1% non-fat dry milk. After
washing, the membranes were developed by the ECL detection
system, and the results were visualised by autoradiography. The
results, shown in figures, are representative of those obtained in
the three or more independent experiments performed.
RESULTS
The original observation that YTX treatment induces fragmenta-
tion of E-cadherin in MCF-7 cells (Pierotti et al, 2003) led us to
ascertain preliminarily whether similar structural alterations could
be detected in components associated with E-cadherin, such as b-
and g-catenins (Ozawa et al, 1989; Mareel et al, 1997). By
immunoblot analysis of cytosoluble extracts, we could observe
that neither the cellular levels nor the general structures of b- and
g-catenins were significantly changed after MCF-7 cells had been
treated for 24h with YTX, when ECRA100 was accumulated
(Figure 1).
Other experiments were then carried out to define the temporal
pattern of E-cadherin fragmentation in YTX-treated MCF-7 cells.
To this end, cultures were treated with 1nM YTX for different times
before extracts were prepared and analysed by immunoblotting,
using an anti-E-cadherin antibody (Figure 2). The results we
obtained confirmed our initial observation that very low levels of
ECRA100 are detected in control cells (Pierotti et al, 2003). An
increase in the concentrations of ECRA100 in cytosoluble extracts
became detectable after a 6h treatment with YTX, reaching
maximal levels 18–24h after toxin addition, whereas other
fragments were detected thereafter (Figure 2).
In line with previous data (Pierotti et al, 2003), a relative
decrease in the concentrations of intact E-cadherin did not appear
to accompany the accumulation of ECRA100 in cytosoluble extracts
of MCF-7 cells in the first day of YTX treatment (Figure 2).
However, a prolonged incubation with YTX eventually led to a
collapse of the E-cadherin system in MCF-7 cells. In the
experiments we have carried out so far, this collapse involved
70–90% losses in the cellular levels of intact E-cadherin that was
detected between 2 and 5 days after YTX addition to cultured cells,
and was accompanied by cell detachment from culture dishes
(Figure 3).
This finding led us to analyse the effect of YTX on MCF-7 cell
proliferation, and we found that cell growth apparently ceased
after 24–48h of treatment with YTX (Figure 4). Extensive MCF-7
cell death, however, did not occur, as the cell content of YTX-
treated cultures did not drop in the following days (Figure 4).
The immunoblot analysis of E-cadherin described above
was performed using the HECD-1 antibody, whose epitope is
located at the amino-terminal in the extracellular domain of
the protein (Shimoyama et al, 1989), supporting the hypothesis
that ECRA100 lacks the carboxy-terminal, intracellular, portion of
the molecule.
An analysis of the general structure of ECRA100 was then
approached by antibodies whose epitopes are located in different
domains of the E-cadherin molecule (Figure 5A). H-108 is a
polyclonal anti-E-cadherin antibody raised against a recombinant
protein corresponding to amino acids 600–707, mapping within
the extracellular domain of the protein of human origin (see
the information sheet of the product (Cat. No. sc-7870) provided
by Santa Cruz Biotechnology). When immunoblot analysis
was carried out with the H-108 anti-E-cadherin antibody, the
 
E-Cadherin   β-Catenin
Y-Catenin Actin
116   -
90   -
90   - 
116   -
116   -
90   - 
53   -
64   -
64   -
YTX 1nM
37   -
YTX 1nM
− + − +
− + − +
Figure 1 Effect of yessotoxin treatment of MCF-7 cells on the
components of the E-cadherin–catenin system. Cells were incubated with
(þ) or without ( )1 n M YTX for 24h at 371C. At the end of the
incubation, cells were processed to prepare cytosoluble extracts, which
were subjected to SDS–PAGE and immunoblotting, using antibodies
recognising the indicated proteins. Extracts loaded onto each lane
contained 10mg of protein, and detection of actin has been included as a
loading control for our procedure. The electrophoretic mobilities of b-
galactosidase (116kDa), fructose-6-phosphate kinase (90kDa), pyruvate
kinase (64kDa), fumarase (53kDa) and lactate dehydrogenase (37kDa)
subunits, used as marker proteins running in a parallel lane, are indicated on
the left.
TIME (h)      0         3          6          12        18        24         48 
90 –
116 – 
Figure 2 Time-course of the fragmentation of E-cadherin induced by
yessotoxin in MCF-7 cells. Cells in logarithmic growth were incubated with
1n M YTX for the times indicated at 371C. At the end of the incubation,
cells were processed to prepare cytosoluble extracts, which were
subjected to SDS–PAGE and immunoblotting, using the HECD-1 anti-E-
cadherin antibody. The electrophoretic mobilities of b-galactosidase
(116kDa) and fructose-6-phosphate kinase (90kDa) subunits, used as
marker proteins running in a parallel lane, are indicated on the left.
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selectrophoretic patterns we detected did not differ from those
found with the HECD-1 antibody (Figure 5B) The monoclonal
C20820 anti-E-cadherin antibody, in turn, whose epitope consists
of the carboxy-terminal, intracellular domain of human E-cadherin
(see the information sheet of the product (Cat. No. C20820)
provided by transduction Laboratories), bound the intact protein,
but could not interact with ECRA100 (Figure 5B).
According to these findings, therefore, ECRA100 consists of an E-
cadherin fragment lacking some of the intracellular domain of the
protein.
Based on these features, we checked whether ECRA100 might be
released from plasma membrane when MCF-7 cells were treated
with YTX. By immunoblot analysis of proteins obtained from
culture media of YTX-treated cells, however, we could not detect
ECRA100, even after the protein concentration of our samples was
concentrated 110-fold by ultrafiltration (data not shown).
The possibility that ECRA100 might partition only in the Triton
X-100 soluble fraction was also evaluated by preparing soluble and
insoluble fractions from control and YTX-treated cells, as
described in the Materials and Methods section. By immunoblot
analysis of the two fractions, we ascertained that part of cellular
ECRA100 is resistant to nonionic detergents, and is detectable in
the Triton X-100 insoluble fraction prepared from YTX-treated
cells (Figure 6).
The intracellular carboxy-terminal domain of E-cadherin con-
tains the binding sites for b- and g-catenins (Ozawa et al, 1989;
Stappert and Kemler, 1994; Jou et al, 1995). Since YTX induces
structural alterations of this portion of E-cadherin, we ascertained
A
B
Figure 3 Effect of yessotoxin on morphology of MCF-7 cells in culture.
Phase contrast microscopy (magnification  200) of MCF-7 cells after
treatment for 4 days with vehicle (A)o r1n M YTX (B).
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Figure 4 Effect of yessotoxin on the proliferation of MCF-7 cells. Cells
were treated with either 1nM yessotoxin (empty circles) or vehicle (filled
circles), and cultures were maintained for the indicated times at 371C,
before being used for measurements of DNA content, as described under
Materials and Methods.
1 nM YTX   −       +         −     +       −    +
116  -- 
  90  -- 
HECD - 1  H - 108  C20820
C  M
HECD - 1  H - 108 C20820 
B 
A 
N 
Figure 5 Characterisation of ECRA100 by immunoblotting. (A) Sche-
matic representation of the E-cadherin molecule, including the transmem-
brane segment (in black) and the localisation of the epitopes bound by the
HECD-1, H-108 and C20820 anti-E-cadherin antibodies. (B) MCF-7 cells
were incubated with 1nM YTX for 24h at 371C. At the end of the
incubation, cells were processed to prepare cytosoluble extracts, which
were subjected to SDS–PAGE and immunoblotting, using the HECD-1, H-
108 and C20820 anti E-cadherin antibodies, as indicated. The electro-
phoretic mobilities of b-galactosidase (116kDa) and fructose-6-phosphate
kinase (90kDa) subunits, used as marker proteins running in a parallel lane,
are indicated on the left.
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swhether it could also affect the association of b- and g-catenins
with E-cadherin. To this end, we immunoprecipitated E-cadherin
using the HECD-1 anti-E-cadherin antibody, and measured the
levels of b- and g-catenins associated with E-cadherin under our
experimental conditions, by SDS–PAGE and immunoblot analysis
of components found in the immunoprecipitates.
The results we obtained are reported in Figure 7, and show that
the levels of b- and g-catenins associated with E-cadherin in our
immunoprecipitates were reduced by more than 60% in samples
from YTX-treated cells, as compared to controls. Thus, cell
treatment with YTX resulted in the disruption of the E-cadherin–
catenin system in MCF-7 cells.
This finding prompted us to probe whether YTX causes
fragmentation of E-cadherin in other epithelial cells. We then
extended our analyses to Caco-2 and MDCK cells, which were
treated for 24h with 1nM YTX and cytosoluble extracts were
analysed. Immunoblotting using the HECD-1 antibody led to the
detection of ECRA100 in extracts from both MCF-7 and Caco-2 cells
treated with YTX, but neither intact E-cadherin nor its ECRA100
fragment were detected in the extracts prepared from MDCK cells
(Figure 8A). The possibility that this result was due to species-
specific differences in the amino-acid sequence of E-cadherin was
then probed, and analyses were repeated using the H-108 anti-E-
cadherin antibody. The results we obtained showed that YTX could
induce accumulation of ECRA100 in the three epithelial cell lines
(Figure 8B).
This finding led us to evaluate whether YTX could induce
fragmentation of other members of the cadherin family. We then
turned our attention to N-cadherin, which represents another well
characterised component of classical cadherins, and is mainly
expressed in cells of neural origin (Takeichi, 1990; Yap et al, 1997;
Tepass et al, 2000).
PC-12 cells, which express N-cadherin (Doherty et al, 1991) and
represent an experimental system amenable of controlled pro-
liferation and differentiation (Greene and Tischler, 1976; Marshall,
1995), were then used in our experiments. Cytosoluble extracts
were prepared after PC-12 cells had been treated for 24h with 1nM
YTX, and were subjected to immunoblotting using an anti-N-
cadherin antibody. The results we obtained showed that the
electrophoretic patterns of samples from YTX-treated cells were
similar to those of extracts from control cells (Figure 9).
In order to check whether those results might depend on the
functional state of PC-12 cells, we repeated the experiment using
116 – 
Precipitate Supernatant 
1 nM YTX  −− + +
Figure 6 Effect of yessotoxin on the distribution of E-cadherin and
ECRA100 between soluble and particulate material prepared from MCF-7
cells. Cells were incubated with 1nM YTX for 24h at 371C, before being
processed to prepare Triton X-100 soluble (supernatant) and insoluble
(precipitate) components, as described under Materials and Methods.
Samples were then subjected to SDS–PAGE and immunoblotting, using
the HECD-1 anti-E-cadherin antibody. The electrophoretic mobility of b-
galactosidase (116kDa) subunits, used as marker proteins running in a
parallel lane, is indicated on the left.
90   -
CYT                             IPPT 
−         + −         +
E-Cadherin 
β-Catenin
γ-Catenin 
116   -
90   -
116   -
116   -
90   -
Figure 7 Effect of yessotoxin treatment of MCF-7 cells on the levels of b-
and g-catenins associated with E-cadherin. MCF-7 cells were treated with
(þ)o rw i t h o u t(  )1 n M YTX for 5 days at 371C. At the end of the
incubation, cells were processed to prepare cytosoluble extracts, which were
subjected to immunoprecipitation using the HECD-1 anti-E-cadherin
antibody, as described under Materials and Methods. Identical aliquots of
cytosoluble extracts (CYT) and of immunoprecipitated material (IPPT) were
subjected to SDS–PAGE and immunoblotting, using antibodies recognising
the indicated proteins. The electrophoretic mobilities of b-galactosidase
(116kDa) and fructose-6-phosphate kinase (90kDa) subunits, used as
marker proteins running in a parallel lane, are indicated on the left.
MDCK Caco-2 MCF-7 
1 nM YTX  
90 –
116 – 
A
B 
1 nM YTX  
MCF-7  MDCK Caco-2
116 – 
90 –
 −         +  −         +  −         +
 −         +  −         +  −         +
Figure 8 Effect of yessotoxin treatment of different epithelial cells on E-
cadherin. MCF-7, Caco-2 and MDCK cells were incubated with 1nM YTX
for 24h at 371C. At the end of the incubation, cells were processed to
prepare cytosoluble extracts, which were subjected to SDS–PAGE and
immunoblotting, using the HECD-1 (a) and H-108 (b) anti-E-cadherin
antibodies. The electrophoretic mobilities of b-galactosidase (116kDa) and
fructose-6-phosphate kinase (90kDa) subunits, used as marker proteins
running in a parallel lane, are indicated on the left.
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sculture conditions involving cells that had not received the
differentiating stimulus of nerve growth factor, growing either in
small clumps, or in monolayers (see Materials and Methods
section). By immunoblotting using the anti-N-cadherin antibody,
no differences in the electrophoretic patterns of N-cadherin were
detected between control and YTX-treated samples in any of the
experimental conditions we have employed (data not shown).
As YTX-induced fragmentation of E-cadherin was found to be
independent of either the species or the tissues of origin of our cell
lines (Figure 8), the results we obtained with N-cadherin could be
due to differences among members of the superfamily of classic
cadherins (Takeichi, 1990; Yap et al, 1997; Tepass et al, 2000).
In order to probe the selectivity of YTX-induced response with
regard to cadherin molecules, we analysed a third member of the
cadherin family, K-cadherin (cadherin-6), in the MCF-7, Caco-2
and MDCK cells, which represents YTX-responsive systems. The
results reported in Figure 6 were obtained when cytosoluble
extracts were analysed by immunoblotting using an anti-K-
cadherin, and showed that no differences were detectable in the
electrophoretic patterns of K-cadherin in samples prepared from
control and YTX-treated cells (Figure 10A). This lack of sensitivity
of the K-cadherin system to YTX was confirmed by the observation
that 5-day treatment of MCF-7 cells with the toxin did not result in
the detection of protein fragments, and led to limited (about 40%)
losses of intact K-cadherin (Figure 10B).
DISCUSSION
The analysis of the effects exerted by YTX on the structure of
members of the cadherin superfamily of cell adhesion proteins has
revealed that the toxin selectively induces the removal of the
intracellular domain of E-cadherin, leading to the disruption of the
E-cadherin–catenin system in MCF-7 cells. No gross alteration,
instead, was detected in N- and K-cadherin, which are separate
members of type I and type II classic cadherins, respectively
(Tanihara et al, 1994; Nollet et al, 2000; Tepass et al, 2000).
The simplest explanation of these findings is that different
members of the cadherin superfamily are not susceptible to the
same kind of proteolytic attack. Alternatively, the possibility that
the molecular machinery affected by YTX might not have the same
features in different cellular systems should be considered. The
first interpretation seems more likely, based on the finding that
YTX causes fragmentation of E-cadherin, but not K-cadherin, in
the same cell lines (Figures 8 and 10). Thus, the different sensitivity
of E- and K-cadherin to YTX would further confirm the conclusion
that the turnovers of the two proteins are independently regulated
by both endogenous and exogenous stimuli (Stewart et al, 2000).
The accumulation of ECRA100 on the first day of YTX treatment
of MCF-7 cells did not cause their massive detachment from
culture dishes. The maintenance of adhesive properties in YTX-
treated cells could be due to the fact that the initial accumulation
of ECRA100 is not apparently accompanied by an extensive loss in
the cellular content of intact E-cadherin (Figure 2), so that an
increase in the total immunoreactivity of samples is observed in
MCF-7 cells (Pierotti et al, 2003). This interpretation would be
supported by the finding that no ECRA100 could be detected in the
culture media of YTX-treated cells. Furthermore, YTX did not
cause a massive redistribution of E-cadherin between Triton X-100
soluble and insoluble fractions (Figure 6), which have been
proposed to include the molecules involved in weak and strong cell
adhesions, respectively (Shore and Nelson, 1991; Chitaev and
Troyanovsky, 1998; Takeda et al, 1999).
It should be noted, however, that K-cadherin was expressed in
our experimental systems, and that our analyses showed that the
general structure and cellular content of K-cadherin were not
significantly affected by YTX treatment in our cell lines. Thus, we
cannot exclude that an intact K-cadherin pool might compensate
for an altered E-cadherin system in both normal (MDCK) and
tumour (MCF-7 and Caco-2) cells. In any case, K-cadherin alone
cannot substitute for E-cadherin, as cell detachment from culture
dishes was observed after prolonged YTX treatment of MCF-7 cells
(Figure 3), when the cellular pool of K-cadherin was not disrupted
yet (Figure 10)
To the best of our knowledge, this is the first report describing
the expression of K-cadherin in breast cancer cells. Indeed, we
have been using MCF-7 cells as a model system to evaluate the
alteration of molecular mechanisms involved in signal transduc-
tion (Rossini et al, 1999; Malaguti and Rossini, 2002). Thus, the
1 nM YTX  + −
90 –
116 – 
Figure 9 Effect of yessotoxin treatment of PC 12 cells on N-cadherin.
Cells were treated with 50nM NGF for 3 days before they were incubated
with 1nM YTX for 24h at 371C. At the end of the incubation, cells were
processed to prepare cytosoluble extracts, which were subjected to SDS–
PAGE and immunoblotting, using the anti-N-cadherin antibody. The
electrophoretic mobilities of b-galactosidase (116kDa) and fructose-6-
phosphate kinase (90kDa) subunits, used as marker proteins running in a
parallel lane, are indicated on the left.
 116 – 
90 –
  64 –
MDCK Caco-2 MCF-7 
1  nM YTX   −        +  −        +  −        + 
TIME  (days)  0 1 2 3 4 5
 116 – 
90 –
A 
B 
Figure 10 Effect of yessotoxin treatment of different epithelial cells on
K-cadherin. (A) MCF-7, Caco-2 and MDCK cells were incubated with 1nM
YTX for 24h at 371C. At the end of the incubation, cells were processed to
prepare cytosoluble extracts, which were subjected to SDS–PAGE and
immunoblotting, using the anti-K-cadherin antibody. (B) Effect of prolonged
yessotoxin treatment of MCF-7 cells on the cellular pool of K-cadherin.
Cells were incubated with 1nM YTX for the times indicated at 371C,
before being processed to prepare cytosoluble extracts, which were
subjected to SDS–PAGE and immunoblotting, using the anti-K-cadherin
antibody. The electrophoretic mobilities of b-galactosidase (116kDa),
fructose-6-phosphate kinase (90kDa) and pyruvate kinase (64kDa)
subunits, used as marker proteins running in a parallel lane, are indicated
on the left.
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sfinding that different epithelial cells can be included among the
targets of an algal toxin contaminating products destined for
human consumption calls for a deeper insight into the possibility
that long-term effects might be caused in the intact organism by
ingestion of low doses of YTX.
The maximal content of YTX contaminating seafood that can be
placed on the market is presently regulated by the legislation of the
European Communities, and is represented by 1mg of YTX
equivalents per kilogram of the edible parts of bivalve molluscs
and other species (European Communities, 2002). This limit has
been set taking into consideration the very low oral toxicity of YTX
and its analogues, based on the analyses of acute responses in mice
(Aune et al, 2002).
Our observations on the disruption of the E-cadherin system
caused by low concentrations of YTX (less than 1mgl
 1)i n
cultured cells should justify other studies aimed at evaluating
whether this compound might induce some delayed type of
adverse effect(s) in intact organisms. This would be particularly
relevant with regard to the intestine epithelium, as the E-cadherin
pool of Caco-2 cells, which has been derived from a human
colorectal adenocarcinoma (Fogh et al, 1977), is altered by YTX.
The possible long-term effects of YTX in intact organism, based
on the results we obtained in the present study, could include the
disruption of the tumour-suppressing function of E-cadherin.
More precisely, our data show that YTX causes both a decrease in
cell adhesion (Figure 3) and in the levels of b- and g-catenins
associated with E-cadherin (Figure 7).
It is recognised that a loss of cell adhesion, as a consequence of
altered E-cadherin participates in tumour spreading and metas-
tasis formation (Birchmeier and Behrens, 1994; Mareel et al, 1997;
Christofori and Semb, 1999; Beavon, 2000). Under our experi-
mental conditions, the YTX-induced detachment of cells from
culture dishes (Figure 3) was accompanied by cell growth arrest
(Figure 4). The proliferation of MCF-7 cells, however, has been
shown to be halted when the cellular E-cadherin pool is reduced,
and the recovery of normal cell growth is observed after the
repletion of normal levels of E-cadherin (Malaguti and Rossini,
2002). Thus, our data could support the working hypothesis that
YTX might facilitate metastasis formation.
In any case, this interpretation should not exclude that YTX
might have other effects by interfering with the Wnt signalling
machinery (Peifer and Polakis, 2000; Zhurinsky et al, 2000; Taipale
and Beachy, 2001), as the loss in b- and g-catenin interacting with
E-cadherin has been found to occur without a concomitant
decrease in the total cytosoluble pool of b- and g-catenin (Figure 7).
Thus, cell treatment with YTX would result in an increased pool of
free b- and g-catenin, which could then interfere with the Wnt
signalling pathway.
In conclusion, the results of the present study show that YTX
induces an alteration of E-cadherin, which determines the
disruption of the E-cadherin–catenin system and has the potential
to disrupt the tumour-suppressive role of E-cadherin.
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